Adapting Regulations Post-Brexit: The UK government is taking advantage of the new regulatory flexibility, afforded by Brexit, to boost the country's competitiveness in pharma.
| Publicado en: | Pharmaceutical Technology Europe Vol. 33; no. 3; pp. 7 - 9 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Mar2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=149520285&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 149520285 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17537967 5NG jtl: Pharmaceutical Technology Europe issn: 17537967 maglogo: N pubinfo: dt: Mar2021 vid: 33 iid: 3 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 149520285 149520285 ppf: 7 ppct: 2 formats: fmt: @attributes: type: P tig: atl: Adapting Regulations Post-Brexit: The UK government is taking advantage of the new regulatory flexibility, afforded by Brexit, to boost the country's competitiveness in pharma. aug: au: Milmo, Sean sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|